The franchise operations, like any other franchise model, hinge on PharmEasy attracting store owners and existing unorganised players in the diagnostics and pharmacy space. While theoretically it ...

As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India CEO Siddharth Shah says the strong bond ...

PharmEasy plans to raise ₹ 6,250 crore through its public issue. The company will use this capital to acquire new businesses and repay loans. Its consolidated revenue tripled to ₹2360 crore in ...